Literature DB >> 22541699

Ascites.

Fredric D Gordon1.   

Abstract

Ascites is the pathologic accumulation of fluid in the peritoneum. It is the most common complication of cirrhosis, with a prevalence of approximately 10%. Over a 10-year period, 50% of patients with previously compensated cirrhosis are expected to develop ascites. As a marker of hepatic decompensation, ascites is associated with a poor prognosis, with only a 56% survival 3 years after onset. In addition, morbidity is increased because of the risk of additional complications, such as spontaneous bacterial peritonitis and hepatorenal syndrome. Understanding the pathophysiology of ascites is essential for its proper management.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22541699     DOI: 10.1016/j.cld.2012.03.004

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  14 in total

1.  Right Atrium Invasion of Tumor Thrombus from Hepatocellular Carcinoma Incidentally Found on Transthoracic Echocardiogram.

Authors:  Tomoki Sempokuya; Dennis T Bolger
Journal:  Hawaii J Med Public Health       Date:  2018-06

2.  Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites.

Authors:  Bashar M Attar; Christopher M Moore; Magdalena George; Nicolae Ion-Nedelcu; Rafael Turbay; Annamma Zachariah; Guiliano Ramadori; Jawed Fareed; David H Van Thiel
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 3.  Palliative care for patients with end-stage liver disease.

Authors:  Anne M Larson
Journal:  Curr Gastroenterol Rep       Date:  2015-05

4.  Metabolomic Analysis Uncovers Lipid and Amino Acid Metabolism Disturbance During the Development of Ascites in Alcoholic Liver Disease.

Authors:  Cheng Cheng; Ming-Xi Zhou; Xian He; Yao Liu; Ying Huang; Ming Niu; Yi-Xuan Liu; Yuan Gao; Ya-Wen Lu; Xin-Hua Song; Hui-Fang Li; Xiao-He Xiao; Jia-Bo Wang; Zhi-Tao Ma
Journal:  Front Med (Lausanne)       Date:  2022-06-13

5.  Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients.

Authors:  Xin Zhang; Shu-Zhen Wang; Jun-Fu Zheng; Wen-Min Zhao; Peng Li; Chun-Lei Fan; Bing Li; Pei-Ling Dong; Lei Li; Hui-Guo Ding
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.

Authors:  Angel Mier Hicks; Joanne Chou; Marinela Capanu; Maeve A Lowery; Kenneth H Yu; Eileen M O'Reilly
Journal:  Clin Colorectal Cancer       Date:  2016-05-07       Impact factor: 4.481

7.  Safety and efficacy of the PleurX catheter for the treatment of malignant ascites.

Authors:  Govindarajan Narayanan; Amir Pezeshkmehr; Shree Venkat; Gabriella Guerrero; Katuzka Barbery
Journal:  J Palliat Med       Date:  2014-06-02       Impact factor: 2.947

8.  Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease.

Authors:  Isabel Legaz; Jose M Bolarin; Jose A Campillo; Rosa M Moya; Aurelio Luna; Eduardo Osuna; Alfredo Minguela; Francisco Sanchez-Bueno; Maria Rocio Alvarez; Manuel Muro
Journal:  Arch Med Sci       Date:  2019-06-18       Impact factor: 3.318

9.  Mathematical model of blood and interstitial flow and lymph production in the liver.

Authors:  Jennifer H Siggers; Kritsada Leungchavaphongse; Chong Hang Ho; Rodolfo Repetto
Journal:  Biomech Model Mechanobiol       Date:  2013-08-02

Review 10.  The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.

Authors:  Masatake Tanaka; Yasuko Iwakiri
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.